Genistein and a soy extract differentially affect three-dimensional bone parameters and bone-specific gene expression in ovariectomized mice.
暂无分享,去创建一个
W. Helferich | M. Wong | Yan Zhang | Qi Li | Hoi-Ying Wan
[1] A. Bitto,et al. Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study. , 2008, The Journal of clinical endocrinology and metabolism.
[2] J. Penninger,et al. RANK/RANKL: Regulators of Immune Responses and Bone Physiology , 2008, Annals of the New York Academy of Sciences.
[3] K. Jeong,et al. Soy extract is more potent than genistein on tumor growth inhibition. , 2008, Anticancer research.
[4] A. Bitto,et al. OPG and sRANKL Serum Concentrations in Osteopenic, Postmenopausal Women After 2‐Year Genistein Administration , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] E. Livne,et al. Daidzein but not other phytoestrogens preserves bone architecture in ovariectomized female rats in vivo , 2008, Journal of cellular biochemistry.
[6] W. Ward,et al. Soy isoflavones and fatty acids: effects on bone tissue postovariectomy in mice. , 2007, Molecular nutrition & food research.
[7] M. Lafage-Proust,et al. Opposite effects of leptin on bone metabolism: a dose-dependent balance related to energy intake and insulin-like growth factor-I pathway. , 2007, Endocrinology.
[8] G. Gilani,et al. Bioavailability of soy isoflavones in rats Part I: application of accurate methodology for studying the effects of gender and source of isoflavones. , 2007, Molecular nutrition & food research.
[9] S. Uchiyama,et al. Genistein and zinc synergistically stimulate apoptotic cell death and suppress RANKL signaling‐related gene expression in osteoclastic cells , 2007, Journal of cellular biochemistry.
[10] N. Suzuki,et al. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells. , 2007, Life sciences.
[11] Chunfu Wu,et al. Anti-osteoporotic effect of Erythrina variegata L. in ovariectomized rats. , 2007, Journal of ethnopharmacology.
[12] U. Iwaniec,et al. Strain‐Dependent Variations in the Response of Cancellous Bone to Ovariectomy in Mice , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[13] Y. Ju,et al. Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations. , 2006, Carcinogenesis.
[14] G. Degen,et al. Effects of genistein on the mammary gland proliferation of adult ovariectomised Wistar rats. , 2006, Planta medica.
[15] G. Vollmer,et al. Effect of phytoestrogens on gene expression of carbonic anhydrase II in rat uterus and liver , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[16] S. Hirano,et al. Effects of the phytoestrogen coumestrol on RANK-ligand-induced differentiation of osteoclasts. , 2004, Toxicology.
[17] Y. Ju,et al. Soy processing influences growth of estrogen-dependent breast cancer tumors. , 2004, Carcinogenesis.
[18] O. Ylikorkala,et al. Effects of phytoestrogens on bone turnover in postmenopausal women with a history of breast cancer. , 2004, The Journal of clinical endocrinology and metabolism.
[19] S. Ho,et al. Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. , 2003, The Journal of clinical endocrinology and metabolism.
[20] S. Davis,et al. Hormone replacement therapy: current controversies , 2003, Clinical endocrinology.
[21] M. Payton,et al. Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. , 2003, The Journal of clinical endocrinology and metabolism.
[22] R. Macdonald,et al. Soy isoflavones increase latency of spontaneous mammary tumors in mice. , 2002, The Journal of nutrition.
[23] Heidi D Nelson,et al. Postmenopausal hormone replacement therapy: scientific review. , 2002, JAMA.
[24] Jingping Liu,et al. The diagnostic criteria for primary osteoporosis and the incidence of osteoporosis in China , 2002, Journal of Bone and Mineral Metabolism.
[25] Y. Ju,et al. Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. , 2001, The Journal of nutrition.
[26] C. Loprinzi,et al. Soy for breast cancer survivors: a critical review of the literature. , 2001, The Journal of nutrition.
[27] S. Ho,et al. Soy Intake and the Maintenance of Peak Bone Mass in Hong Kong Chinese Women , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[28] M. A. Bowman,et al. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. , 2001, Archives of internal medicine.
[29] V. Coxam,et al. Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. , 2001, The Journal of nutrition.
[30] V. Coxam,et al. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. , 2000, The Journal of nutrition.
[31] K. M. Chan,et al. The prevalence of osteoporosis in the Hong Kong Chinese female population. , 1999, Maturitas.
[32] Y. Ishimi,et al. Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. , 1999, Endocrinology.
[33] R. Turner. Mice, Estrogen, and Postmenopausal Osteoporosis , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[34] P. Lehenkari,et al. Carbonic anhydrase II plays a major role in osteoclast differentiation and bone resorption by effecting the steady state intracellular pH and Ca2+. , 1998, Experimental cell research.
[35] William L. Haskell,et al. Potential Health Benefits of Dietary Phytoestrogens: A Review of the Clinical, Epidemiological, and Mechanistic Evidence1 , 1998 .
[36] C D Gardner,et al. Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. , 1998, The Journal of clinical endocrinology and metabolism.
[37] P. Morris,et al. The Phytoestrogen Genistein Reduces Bone Loss in Short-Term Ovariectomized Rats , 1998, Osteoporosis International.
[38] W. Mazur,et al. Phyto-oestrogens and Western diseases. , 1997, Annals of medicine.
[39] B. Hollis,et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. , 1996, The Journal of nutrition.
[40] R. Turner,et al. The effect of long-term ovarian hormone deficiency on transforming growth factor-beta and bone matrix protein mRNA expression in rat femora. , 1994, Biochemical and biophysical research communications.
[41] P. G. Reeves,et al. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. , 1993, The Journal of nutrition.